{"brief_title": "Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia", "brief_summary": "To compare the efficacy and safety of the tigecycline regimen with that of the imipenem/cilastatin regimen in subjects with nosocomial pneumonia.", "condition": "Bacterial Pneumonia", "intervention_type": "Drug", "intervention_name": "Cilastatin", "criteria": "Inclusion Criteria: - Male or female subjects over 18 years of age. Bulgaria Only: Male or female subjects over 18 years of age and under 70 years of age. - Subjects known or suspected to have acute hospital-acquired pneumonia. Exclusion Criteria: - Presence of any of the following pulmonary conditions: cystic fibrosis; pulmonary malignancy (either primary or metastatic); known bronchial-obstructive or post obstructive pneumonia; pulmonary abscess; empyema; known or suspected active tuberculosis; bronchiectasis; sarcoidosis; known or suspected pulmonary infection caused by Pneumocystis carinii, mycobacteria, fungi, parasites, or viruses (Subjects with COPD are not excluded) - Suspected or known Legionella infection - Concurrent hemodialysis, hemofiltration, peritoneal dialysis, or plasmapheresis", "gender": "All", "minimum_age": "18 Years", "maximum_age": "70 Years", "healthy_volunteers": "No", "id": "NCT00080496.xml"}